Lincoln Capital Corp Amgen Inc Transaction History

Lincoln Capital Corp

$240 Million
Q3 2024

A detailed history of Lincoln Capital Corp transactions in Amgen Inc stock. As of the latest transaction made, Lincoln Capital Corp holds 1,633 shares of AMGN stock, worth $457,354. This represents 0.22% of its overall portfolio holdings.

Number of Shares

1,633

Previous 1,943 15.95%

Holding current value

$457,354

Previous $607,000 13.34%

% of portfolio

0.22%

Previous 0.27%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$309.38 - $337.38 $95,907 - $104,587	-310 Reduced 15.95%	1,633 $526,000
Q2 2024 Jul 23, 2024	BUY	$262.75 - $319.31 $51,236 - $62,265	195 Added 11.16%	1,943 $607,000
Q3 2023 Nov 02, 2023	SELL	$218.65 - $271.46 $59,035 - $73,294	-270 Reduced 13.38%	1,748 $469,000
Q1 2023 Apr 20, 2023	BUY	$225.79 - $275.2 $22,579 - $27,520	100 Added 5.21%	2,018 $487,000
Q2 2022 Jul 22, 2022	BUY	$230.71 - $256.74 $38,067 - $42,362	165 Added 9.41%	1,918 $467,000
Q1 2022 Apr 19, 2022	SELL	$219.27 - $242.57 $182,651 - $202,060	-833 Reduced 32.21%	1,753 $424,000
Q4 2021 Jan 24, 2022	SELL	$198.88 - $227.6 $131,857 - $150,898	-663 Reduced 20.41%	2,586 $582,000
Q3 2021 Oct 18, 2021	SELL	$212.27 - $248.7 $3.18 Million - $3.73 Million	-14,993 Reduced 82.19%	3,249 $691,000
Q2 2021 Jul 22, 2021	SELL	$233.58 - $259.14 $106,045 - $117,649	-454 Reduced 2.43%	18,242 $4.45 Million
Q1 2021 Apr 20, 2021	SELL	$221.91 - $258.6 $805,755 - $938,976	-3,631 Reduced 16.26%	18,696 $4.65 Million
Q4 2020 Feb 05, 2021	SELL	$216.38 - $257.67 $139,997 - $166,712	-647 Reduced 2.82%	22,327 $5.13 Million
Q3 2020 Nov 04, 2020	SELL	$234.65 - $260.95 $65,232 - $72,544	-278 Reduced 1.2%	22,974 $5.84 Million
Q2 2020 Jul 22, 2020	BUY	$197.81 - $242.74 $68,640 - $84,230	347 Added 1.51%	23,252 $5.48 Million
Q1 2020 Apr 16, 2020	BUY	$182.24 - $241.7 $181,511 - $240,733	996 Added 4.55%	22,905 $4.64 Million
Q4 2019 Jan 17, 2020	SELL	$189.21 - $243.2 $64,142 - $82,444	-339 Reduced 1.52%	21,909 $5.28 Million
Q3 2019 Nov 05, 2019	BUY	$174.11 - $208.62 $133,194 - $159,594	765 Added 3.56%	22,248 $4.31 Million
Q2 2019 Jul 12, 2019	BUY	$166.7 - $195.41 $9,668 - $11,333	58 Added 0.27%	21,483 $3.96 Million
Q1 2019 Apr 11, 2019	BUY	$180.87 - $203.88 $23,693 - $26,708	131 Added 0.62%	21,425 $4.07 Million
Q4 2018 Jan 22, 2019	SELL	$178.4 - $208.25 $106,326 - $124,117	-596 Reduced 2.72%	21,294 $4.15 Million
Q3 2018 Oct 10, 2018	BUY	$185.29 - $208.89 $1.2 Million - $1.35 Million	6,478 Added 42.03%	21,890 $4.54 Million
Q2 2018 Jul 26, 2018	SELL	$166.05 - $186.51 $1.17 Million - $1.31 Million	-7,037 Reduced 31.35%	15,412 $2.85 Million
Q1 2018 Apr 12, 2018	BUY	$169.43 - $198.0 $780,225 - $911,790	4,605 Added 25.81%	22,449 $3.83 Million
Q4 2017 Feb 06, 2018	SELL	$168.79 - $188.59 $107,350 - $119,943	-636 Reduced 3.44%	17,844 $3.1 Million
Q3 2017 Oct 18, 2017	BUY	$167.29 - $191.0 $3.09 Million - $3.53 Million	18,480	18,480 $3.45 Million

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lincoln Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lincoln Capital Corp with notifications on news.

Account

Lincoln Capital Corp Amgen Inc Transaction History